Ultragenyx is a pharmaceutical company in Novato, California, developing drug and gene therapy candidates for disease states. It last closed at $16.70 on Nov 17, up 5.03% on the day. RARE reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 15 analysts is $24.53 (+46.9% from the last close), with a high of $39.00 and a low of $16.00. Analyst consensus is Hold, based on the latest ratings from 15 firms (7 buy, 8 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in RARE, 100% of them bullish and 0% bearish. In the past 30 days there were 1 dark pool print totaling $2.5M, the largest $2.5M.
Each firm's latest rating on RARE in the past 90 days
Average 12-month target
$24.53
▲ 46.9% upside
Based on 15 analysts who set a price target on RARE in the past 90 days. The average target is $24.53, with a high of $39.00 and a low of $16.00, compared with the last close of $16.70.
Highest target$39.00
Average target$24.53
Lowest target$16.00
Latest rating changes
CitigroupTarget lowered
Nov 5Buy$32 → $22
Canaccord GenuityTarget lowered
Nov 4Buy$39 → $34
TD CowenTarget raised
Nov 4Buy$18 → $19
Morgan StanleyTarget raised
Nov 4Hold$20 → $22
Goldman SachsTarget lowered
Nov 4Hold$19 → $17
Date
Firm
Action
Rating
Price target
Nov 5
Citigroup
Target lowered
Buy
$32 → $22
Nov 4
Canaccord Genuity
Target lowered
Buy
$39 → $34
Nov 4
TD Cowen
Target raised
Buy
$18 → $19
Nov 4
Morgan Stanley
Target raised
Hold
$20 → $22
Nov 4
Goldman Sachs
Target lowered
Hold
$19 → $17
Loading…
Technical Analysis
RARE · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend
The stock is 2% above its 20 day and 8% above its 50 day average. It is 34% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 54). The nearest support is the Pivot at $16.36, and the nearest resistance the swing high (Nov 11) at $16.77.
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 5.2%/day
Key levels
$39.8952 week high+138.9%
$22.45200 day average+34.4%
$21.37100 day average+28.0%
$17.08Pivot R1+2.3%
$16.77Swing high (Nov 11)+0.4%
$16.70Last close
$16.36Pivot−2.0%
$16.2920 day average−2.5%
$15.99Pivot S1−4.3%
$15.3450 day average−8.1%
$15.12Swing low (Nov 6)−9.5%
$12.7352 week low−23.8%
Indicators
RSI (14)
53.84
Middle of its range
Neutral
MACD
0.05
Above its signal line
Bullish
Stochastic
43.6
Middle of its range
Neutral
ADX (14)
16.4
No clear trend
Williams %R
-37.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
18.6
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.4%
Change over 10 sessions
Bullish
ATR (14)
$0.86
Typical daily range, 5.2% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityHigh, 15.9%/day
Key levels
$39.8952 week high+138.9%
$22.45200 day average+34.4%
$21.37100 day average+28.0%
$17.08Pivot R1+2.3%
$16.77Swing high (Nov 11)+0.4%
$16.70Last close
$16.36Pivot−2.0%
$16.2920 day average−2.5%
$15.99Pivot S1−4.3%
$15.3450 day average−8.1%
$15.12Swing low (Nov 6)−9.5%
$12.7352 week low−23.8%
Indicators
RSI (14)
40.40
Middle of its range
Neutral
MACD
-2.74
Below its signal line
Bearish
Stochastic
21.2
Middle of its range
Neutral
ADX (14)
23.5
Weak trend
Williams %R
-74.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
-47.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+16.8%
Change over 10 sessions
Bullish
ATR (14)
$2.66
Typical daily range, 15.9% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for RARE
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RARE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow RARE usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How RARE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RARE is in one of them and how their past RARE trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Ultragenyx Pharmaceutical
Ultragenyx is a pharmaceutical company based in Novato, California. It is developing drug candidates, including gene therapy candidates that use AAV vectors, for a range of disease states. Its work is aimed at patients, physicians and healthcare providers who would use any approved treatments, and it works with regulators such as the FDA and the EMA to define approval paths.